Quick Overview: Advances are coming in subsets for patients with cancers. Newer drugs are like lock and key; the lock has to be present for the ... Highlights from ASCO on the science surrounding cholangiocarcinoma, with Dr. Haley Ellis. Recorded June 29, 2023. Biomarkers are mutations on cancer cells that we can test for and sometimes treat. How do we find them, how did they get there, ...
Ccf Webinar How Liquid Biopsies - Detailed Overview & Context
Advances are coming in subsets for patients with cancers. Newer drugs are like lock and key; the lock has to be present for the ... Highlights from ASCO on the science surrounding cholangiocarcinoma, with Dr. Haley Ellis. Recorded June 29, 2023. Biomarkers are mutations on cancer cells that we can test for and sometimes treat. How do we find them, how did they get there, ... Join ACCRF grantee Dr. Daniel Pelaez for a presentation and discussion on March 22, 2017 Dr. Pierre-Jean Lamy from Imagenome and Dr. Darryl Irwin from Agena Bioscience discuss the current research ... Day 2 Technical insights into ctDNA: Which platform to use? Francesco Facchinetti Incorporating ctDNA in clinical trial design ...
Moderators K. Junker, Homburg (DE) G. Jenster, Rotterdam (NL) Presenter(s) K. Pantel, Hamburg (DE) L. Dyrskjøt, Aarhus (DK) K. Cholangiocarcinoma, or bile duct cancer, can be challenging to manage. Join us to learn about a new, personalized approach ... Precision medicine promises a more effective approach to disease treatment and management. It is based on analyzing mutations ... Klaus Pantel, Chairman of the Institute of Tumor Biology at University Medical Center Hamburg-Eppendorf, reviews how Stephen Bagley, MD, MSCE, University of Pennsylvania, Philadelphia, PA, comments on the potential of using cerebrospinal Presented By: Monika Seidel Speaker Biography: Monika Seidel is the scientific lead on new product development from ...
Stephen Bagley, MD, MSCE, Assistant Professor of Medicine at the University of Pennsylvania, provides an overview of the ... Sven Borchmann, MD, University of Cologne, Cologne, Germany, touches on the potential of circulating tumor DNA (ctDNA) and ... Natasha Leighl, BSc, MMSc, MD, Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, Canada, discusses ... Earn CME credit for a related activity: In this presentation from Lymphoma & Myeloma 2018, Dr.
